Aarti Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.20 M
as on 16-11-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 96.48%
(FY 2023)
- Ebitda 96.48%
(FY 2023)
- Net Worth -4.16%
(FY 2023)
- Total Assets -79.28%
(FY 2023)
About Aarti Speciality Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.20 M, as per Ministry of Corporate Affairs (MCA) records.
Harshit Savla, Harit Shah, and Adhish Patil serve as directors at the Company.
- CIN/LLPIN
U24230MH2019PLC333306
- Company No.
333306
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2019
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aarti Speciality Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshit Savla  | Director | Current | |
| Harit Shah | Director | 27-Nov-2019 | Current |
| Adhish Patil | Director | 20-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Aarti Speciality Chemicals.
Aarti Speciality Chemicals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 96.48% increase in profit. The company's net worth dipped by a decrease of 4.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarti Speciality Chemicals?
In 2023, Aarti Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pinnacle Life Science Private LimitedActive 21 years 11 monthsHarshit Savla, Harit Shah and 1 more are mutual person
Harshit Ventures Limited Liability Partn ErshipActive 14 years 7 monthsHarshit Savla and Harit Shah are mutual person
- Aarti Life Science LlpActive 12 years 8 months
Harshit Savla, Harit Shah and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aarti Speciality Chemicals?
Unlock and access historical data on people associated with Aarti Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarti Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarti Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
